Regencell Bioscience Holdings Ltd (RGC): Net Income

Annual figures by period end, from SEC filings.

-$3.58M

Year ended 2025-06-30

2019-06-30 Net Income (USD) 2025-06-30

Period ended	Net Income	Change YoY	Source filing
2025-06-30	-$3.58M	n/m	2025-10-31, From 2024-07-01
2024-06-30	-$4.30M	n/m	2025-10-31, From 2023-07-01
2023-06-30	-$5.87M	n/m	2025-10-31, From 2022-07-01
2022-06-30	-$7.45M	n/m	2024-10-25, From 2021-07-01
2021-06-30	-$1.35M	n/m	2023-10-27, From 2020-07-01
2020-06-30	-$812.4K	n/m	2021-10-29, From 2019-07-01
2019-06-30	-$391.0K	n/a	2021-10-29, From 2018-07-01

Net Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Regencell Bioscience Holdings Ltd (RGC)	2025-06-30	-$3.58M	n/m
Target Group Inc. (CBDY)	2025-12-31	-$1.36M	n/m
TFA Therapeutics, Inc. (RAJAF)	2025-12-31	-$154.8K	n/m
Functional Brands Inc. (MEHA)	2025-12-31	$758.5K	n/m
Synergy CHC Corp. (SNYRQ)	2025-12-31	-$12.34M	n/m
Charlie's Holdings, Inc. (CHUC)	2025-12-31	$4.50M	n/m
Cyanotech Corp (CYAN)	2025-03-31	-$3.20M	n/m
Healthy Extracts Inc. (HYEX)	2025-12-31	-$881.1K	n/m
Mannatech Inc (MTEX)	2025-12-31	-$15.21M	n/m

Compare RGC, CBDY, RAJAF, MEHA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗